Xinyi Jiang
Impact in
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
Papers in
- Immunology 28
- Immune cells in cancer 13
- Immunotherapy and Immune Responses 6
- Phagocytosis and Immune Regulation 6
- Biomaterials 14
- Nanoparticle-Based Drug Delivery 12
- Co-authors
- Xiaoling FangXianyi ShaHongliang XinLiangcen ChenJijin GuYanzuo ChenFan YangJing Zhang
- Journals
- Biomaterials (11 papers)International Journal of Pharmaceutics (5 papers)Advanced Materials (5 papers)International Journal of Molecular Sciences (3 papers)Chemosphere (3 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Xinyi Jiang
139 papers receiving 4.1k citations
Hit Papers
Peers
Comparison fields: 5 of 175
- Biomaterials 1.3k
- Pharmaceutical Science 235
- Genetics 308
- Biomedical Engineering 1.2k
- Molecular Biology 1.5k
Countries citing papers authored by Xinyi Jiang
This map shows the geographic impact of Xinyi Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinyi Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinyi Jiang more than expected).
Fields of papers citing papers by Xinyi Jiang
This network shows the impact of papers produced by Xinyi Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinyi Jiang. The network helps show where Xinyi Jiang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xinyi Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2025 | 6 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 15 | |
| 10 | 2024 | 10 | |
| 11 | 2024 | 1 | |
| 12 | 2024 | 28 | |
| 13 | 2024 | 0 | |
| 14 | 2023 | 9 | |
| 15 | 2023 | 8 | |
| 16 | 2023 | 8 | |
| 17 | 2023 | 18 | |
| 18 | 2023 | 11 | |
| 19 | 2023 | 0 | |
| 20 | 2009 | 9 |
About Xinyi Jiang
Xinyi Jiang is a scholar working on Immunology, Biomaterials, Biomedical Engineering, Genetics and Analytical Chemistry, having authored 150 papers that have together received 4.1k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (20 papers), Immune cells in cancer (13 papers), Nanoparticle-Based Drug Delivery (12 papers), RNA Interference and Gene Delivery (10 papers), Glioma Diagnosis and Treatment (6 papers), Advanced biosensing and bioanalysis techniques (6 papers), Immunotherapy and Immune Responses (6 papers) and Phagocytosis and Immune Regulation (6 papers). The work is most often cited by research in Biomaterials (1.3k citations), Pharmaceutical Science (235 citations), Genetics (308 citations), Biomedical Engineering (1.2k citations) and Molecular Biology (1.5k citations). Xinyi Jiang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Xiaoling Fang, Xianyi Sha, Hongliang Xin, Liangcen Chen, Jijin Gu, Yanzuo Chen, Fan Yang, Jing Zhang, Wei Zhang and Xiao Wang. Their work appears in journals such as Biomaterials, International Journal of Pharmaceutics, Advanced Materials, International Journal of Molecular Sciences and Chemosphere.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.